VF
HBIO icon

Virtu Financial’s Harvard Bioscience HBIO Stock Holding History

Virtu Financial’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,951
Closed -$40K – 1910
2025
Q4 		$40K Buy
+5,951
New +$35.3K ﹤0.01% 1329
2025
Q3 		– Sell
-2,654
Closed -$12K – 1721
2025
Q2 		$12K Buy
+2,654
New +$11.1K ﹤0.01% 1304
2024
Q3 		– Sell
-3,539
Closed -$101K – 1569
2024
Q2 		$101K Buy
+3,539
New +$124K 0.01% 827
2023
Q3 		– Sell
-2,001
Closed -$110K – 1537
2023
Q2 		$110K Buy
+2,001
New +$110K 0.01% 1016
2022
Q4 		– Sell
-1,792
Closed -$46K – 1834
2022
Q3 		$46K Buy
+1,792
New +$59.3K ﹤0.01% 1221
2019
Q3 		– Sell
-4,329
Closed -$87K – 1574
2019
Q2 		$87K Buy
+4,329
New +$127K 0.01% 1152

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return